查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1422916

2024-2032 年按類型、年齡層、配銷通路、應用、最終用途和地區分類的黏稠補充劑市場

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2023年全球黏稠補充劑市場規模達到45億美元。展望未來， IMARC Group預計到2032年市場規模將達到87億美元，2024-2032年複合年成長率（CAGR）為7.42%。骨質疏鬆症和骨關節炎（OA）盛行率的增加以及消費者對微創非手術治療的傾向的轉變是推動市場發展的一些關鍵因素。

黏性補充代表一種微創醫療程序，其中將包含被稱為外源性液壓酸（HA）衍生物的凝膠狀流體的關節內注射直接施用到患者的膝關節中。它充當潤滑劑，使骨骼能夠在彼此之間平滑移動，減少炎症，並充當關節負荷的減震器。黏液補充可減少運動過程中的摩擦，幫助滑液產生更多緩衝，消除劇烈疼痛，並增強關節的運動或活動範圍。除此之外，它還能恢復滑液的流變特性，進而產生機械、鎮痛、抗發炎和軟骨保護作用。因此，黏彈性補充被廣泛用於治療膝關節、髖部和手骨關節炎。目前主要有中、低、高分子量。

粘稠補充劑市場趨勢：

骨質疏鬆症和骨關節炎（OA）盛行率的增加是推動市場成長的關鍵因素之一。與此一致的是，消費者對微創非手術治療方案的傾向不斷變化，促進了醫療保健領域廣泛採用黏彈性補充劑來治療皮質類固醇和關節疼痛。反過來，這也是另一個主要的成長誘導因素。消費者對非手術治療的多重好處的認知不斷增強，包括無需住院、費用更少、併發症最少以及更好的臨床結果和康復率，進一步影響了這一點。此外，政府的有利措施和各製藥公司為推出新藥和不同給藥途徑而進行的大量投資正在支持市場成長。此外，門診手術中心（ACS）的出現，提供強化治療，解決身體各部位（如關節、韌帶、肌肉、脊椎和神經）的手術和非手術問題，有利於市場成長。此外，開放標籤單注射液壓酸的推出正在推動市場成長。除此之外，有利的醫療保險報銷政策、易患慢性疾病的老年人口不斷增加、慢性殘疾人數不斷增加、主要參與者之間的合作和夥伴關係以及該領域持續的研發活動醫學科學的發展對市場成長產生正面影響。

本報告回答的關鍵問題：

  • 迄今為止，全球黏稠補充劑市場表現如何，未來幾年將如何表現？
  • 全球黏稠補充劑市場的促進因素、限制因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的黏稠補充市場？
  • 依類型分類市場是怎麼樣的？
  • 市場按年齡層分類是怎樣的？
  • 基於配銷通路的市場區隔是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 根據最終用途分類的市場是怎樣的？
  • 全球黏稠補充劑市場的競爭結構如何？
  • 誰是全球黏稠補充劑市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球黏稠補充劑市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 單次注射
    • 市場走向
    • 市場預測
  • 三注射
    • 市場走向
    • 市場預測
  • 五注射
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依年齡段

  • 成年人
    • 市場走向
    • 市場預測
  • 老年醫學
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按應用

  • 膝骨關節炎
    • 市場走向
    • 市場預測
  • 髖骨關節炎
    • 市場走向
    • 市場預測
  • 手部骨關節炎
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：最終用途別

  • 醫院
    • 市場走向
    • 市場預測
  • 骨科診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Anika Therapeutics Inc.
    • Aptissen SA
    • Bioventus LLC
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici SpA
    • Johnson & Johnson
    • LG Chem Ltd.
    • OrthogenRx Inc. (Avanos Medical Inc.)
    • Sanofi SA
    • Seikagaku Corporation
    • Virchow Biotech Private Limited
    • Zimmer Biomet
    • Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
Product Code: SR112024A6931

Abstract

The global viscosupplementation market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.

Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.

Viscosupplementation Market Trends:

The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global viscosupplementation market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type, age group, distribution channel, application and end use.

Type Insights:

Single Injection

Three Injection

Five Injection

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.

Age Group Insights:

Adults

Geriatrics

A detailed breakup and analysis of the viscosupplementation market based on the age group has also been provided in the report. This includes adults and geriatric. According to the report, geriatrics accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Application Insights:

Knee Osteoarthritis

Hip Osteoarthritis

Hand Osteoarthritis

Others

A detailed breakup and analysis of the viscosupplementation market based on the application has also been provided in the report. This includes knee, hip and hand osteoarthritis. According to the report, knee osteoarthritis accounted for the largest market share.

End Use Insights:

Hospitals

Orthopedic Clinics

Others

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.

Key Questions Answered in This Report:

  • How has the global viscosupplementation market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global viscosupplementation market?
  • What are the key regional markets?
  • Which countries represent the most attractive viscosupplementation markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What is the competitive structure of the global viscosupplementation market?
  • Who are the key players/companies in the global viscosupplementation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viscosupplementation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single Injection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Three Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Five Injection
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Adults
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Geriatrics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Knee Osteoarthritis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hip Osteoarthritis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hand Osteoarthritis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Orthopedic Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Anika Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Aptissen S.A.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Bioventus LLC
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Ferring Pharmaceuticals
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Fidia Farmaceutici S.p.A.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Johnson & Johnson
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 LG Chem Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 OrthogenRx Inc. (Avanos Medical Inc.)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Sanofi S.A.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Seikagaku Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Virchow Biotech Private Limited
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zimmer Biomet
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Viscosupplementation Market: Major Drivers and Challenges
  • Figure 2: Global: Viscosupplementation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Viscosupplementation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Viscosupplementation Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Viscosupplementation Market: Breakup by Age Group (in %), 2023
  • Figure 6: Global: Viscosupplementation Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Viscosupplementation Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Viscosupplementation Market: Breakup by End Use (in %), 2023
  • Figure 9: Global: Viscosupplementation Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Viscosupplementation (Single Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Viscosupplementation (Single Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Viscosupplementation (Three Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Viscosupplementation (Three Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Viscosupplementation (Five Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Viscosupplementation (Five Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Viscosupplementation (Adults) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Viscosupplementation (Adults) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Viscosupplementation (Geriatrics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Viscosupplementation (Geriatrics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Viscosupplementation (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Viscosupplementation (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Viscosupplementation (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Viscosupplementation (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Viscosupplementation (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Viscosupplementation (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Viscosupplementation (Knee Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Viscosupplementation (Knee Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Viscosupplementation (Hip Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Viscosupplementation (Hip Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Viscosupplementation (Hand Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Viscosupplementation (Hand Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Viscosupplementation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Viscosupplementation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Viscosupplementation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Viscosupplementation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Viscosupplementation (Orthopedic Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Viscosupplementation (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Viscosupplementation (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Viscosupplementation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Viscosupplementation Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Viscosupplementation Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Viscosupplementation Industry: Value Chain Analysis
  • Figure 91: Global: Viscosupplementation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viscosupplementation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Viscosupplementation Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Viscosupplementation Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 4: Global: Viscosupplementation Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Viscosupplementation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Viscosupplementation Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 7: Global: Viscosupplementation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Viscosupplementation Market: Competitive Structure
  • Table 9: Global: Viscosupplementation Market: Key Players